<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/662"/><api:result><api:object category="publication" id="662" last-affected-when="2024-04-14T23:18:59.597+01:00" last-modified-when="2024-04-14T23:18:59.597+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/662" created-when="2010-05-17T13:46:25.063+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-01-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="358986" source-id="1" source-name="manual" source-display-name="Manual" id-at-source="87E4ACF3-8669-4EA9-9839-2B2525439B12" last-modified-when="2014-07-25T11:04:48.82+01:00"><api:verification-status>verified</api:verification-status><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Recent identification in bone of transporters, receptors, and components of synaptic signaling suggests a role for glutamate in the skeleton. We investigated effects of glutamate and its antagonist MK801 on osteoclasts in vitro. Glutamate applied to patch clamped osteoclasts induced significant increases in whole-cell membrane currents (P&lt;0.01) in the presence of the coagonist glycine. Agonist-elicited currents were significantly decreased after application of MK801 (100 microM, P&lt;0.01), but MK801 had no effect on actin ring formation necessary for osteoclast polarization, attachment, and resorption. In cocultures of bone marrow cells and osteoblasts in which osteoclasts develop, MK801 inhibited osteoclast differentiation and reduced resorption of pits in dentine (3 to 100 microM; P&lt;0.001). MK801 added early in the culture (for as little as 2-4 days) was as effective as addition for the entire culture period. Addition of MK801 for any time after day 7 of culture was ineffective in reducing osteoclast activity. Using rat and rabbit mature osteoclasts cultured on dentine or explants of mouse calvariae prelabeled with (45)Ca, we could not detect significant effects of MK801 on osteoclastic resorption. These data show clearly that glutamate receptor function is critical during osteoclastogenesis and suggest that glutamate is less important in regulating mature osteoclast activity.-Peet, N. M., Grabowski, P. S., Laketic-Ljubojevic, I., Skerry, T. M. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Peet</api:last-name><api:initials>NM</api:initials><api:first-names>NM</api:first-names><api:separate-first-names><api:first-name>N</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1105" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1105"/></api:links><api:last-name>Grabowski</api:last-name><api:initials>PS</api:initials><api:first-names>PS</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Laketic-Ljubojevic</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1530-6860</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0892-6638</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>15</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The FASEB Journal</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Actins Animals Bone Resorption Cell Differentiation Dizocilpine Maleate Excitatory Amino Acid Antagonists Glutamic Acid Ligands Mice N-Methylaspartate Osteoclasts Patch-Clamp Techniques Rabbits Rats Receptors, N-Methyl-D-Aspartate metabolism metabolism drug effects pharmacology pharmacology metabolism antagonists &amp; inhibitors drug effects metabolism</api:keyword></api:keywords></api:field><api:field name="notes" type="text" display-name="Other information"><api:text>The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation
In Vitro Journal Article Research Support, Non-U.S. Gov't 8804484 United states
English</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2179</api:begin-page><api:end-page>2185</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>17</api:day><api:month>1</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" id="2370248" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1096/fasebj.13.15.2179" last-modified-when="2022-09-10T20:14:19.84+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>PEET</api:last-name><api:initials>NM</api:initials><api:first-names>NICKY M</api:first-names><api:separate-first-names><api:first-name>NICKY</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1105" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1105"/></api:links><api:last-name>GRABOWSKI</api:last-name><api:initials>PS</api:initials><api:first-names>PETER S</api:first-names><api:separate-first-names><api:first-name>PETER</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>LAKETIć‐LJUBOJEVIć</api:last-name><api:initials>IRA</api:initials><api:first-names>IRA</api:first-names><api:separate-first-names><api:first-name>I</api:first-name><api:first-name>R</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>SKERRY</api:last-name><api:initials>TM</api:initials><api:first-names>TIM M</api:first-names><api:separate-first-names><api:first-name>TIM</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1096/fasebj.13.15.2179</api:text><api:links><api:link type="doi" href="http://doi.org/10.1096/fasebj.13.15.2179"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1096/fasebj.13.15.2179"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1530-6860</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0892-6638</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>15</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The FASEB Journal</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2179</api:begin-page><api:end-page>2185</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1096/fasebj.13.15.2179</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>13</api:day><api:month>8</api:month><api:year>2022</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The glutamate receptor antagonist MK801 modulates bone resorption&lt;i&gt;in vitro&lt;/i&gt;by a mechanism predominantly involving osteoclast differentiation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" id="94411" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032763911" last-modified-when="2023-09-27T04:27:08.417+01:00"><api:citation-count>96</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Recent identification in bone of transporters, receptors, and components of synaptic signaling suggests a role for glutamate in the skeleton. We investigated effects of glutamate and its antagonist MK801 on osteoclasts in vitro. Glutamate applied to patch clamped osteoclasts induced significant increases in whole-cell membrane currents (P&lt;0.01) in the presence of the coagonist glycine. Agonist-elicited currents were significantly decreased after application of MK801 (100 μM, P&lt;0.01), but MK801 had no effect on actin ring formation necessary for osteoclast polarization, attachment, and resorption. In cocultures of bone marrow cells and osteoblasts in which osteoclasts develop, MK801 inhibited osteoclast differentiation and reduced resorption of pits in dentine (3 to 100 μM; P&lt;0.001). MK801 added early in the culture (for as little as 2-4 days) was as effective as addition for the entire culture period. Addition of MK801 for any time after day 7 of culture was ineffective in reducing osteoclast activity. Using rat and rabbit mature osteoclasts cultured on dentine or explants of mouse calvariae prelabeled with 45Ca, we could not detect significant effects of MK801 on osteoclastic resorption. These data show clearly that glutamate receptor function is critical during osteoclastogenesis and suggest that glutamate is less important in regulating mature osteoclast activity. - Peet, N.M., Grabowski, P.S., Laketic-Ljubojevic, I., Skerry, T. M. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Peet</api:last-name><api:initials>NM</api:initials><api:first-names>NM</api:first-names><api:separate-first-names><api:first-name>N</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of York</api:line><api:line type="city">York</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006087840</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1105" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1105"/></api:links><api:last-name>Grabowski</api:last-name><api:initials>PS</api:initials><api:first-names>PS</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of York</api:line><api:line type="city">York</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005816455</api:identifier></api:identifiers></api:person><api:person><api:last-name>Laketić-Ljubojević</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of York</api:line><api:line type="city">York</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">21334771200</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of York</api:line><api:line type="city">York</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7004271201</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1096/fasebj.13.15.2179</api:text><api:links><api:link type="doi" href="http://doi.org/10.1096/fasebj.13.15.2179"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1096/fasebj.13.15.2179"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10593865</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0892-6638</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>15</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>FASEB Journal</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2179</api:begin-page><api:end-page>2185</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" id="662" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10593865" last-modified-when="2020-04-29T04:09:37.987+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Recent identification in bone of transporters, receptors, and components of synaptic signaling suggests a role for glutamate in the skeleton. We investigated effects of glutamate and its antagonist MK801 on osteoclasts in vitro. Glutamate applied to patch clamped osteoclasts induced significant increases in whole-cell membrane currents (P&lt;0.01) in the presence of the coagonist glycine. Agonist-elicited currents were significantly decreased after application of MK801 (100 microM, P&lt;0.01), but MK801 had no effect on actin ring formation necessary for osteoclast polarization, attachment, and resorption. In cocultures of bone marrow cells and osteoblasts in which osteoclasts develop, MK801 inhibited osteoclast differentiation and reduced resorption of pits in dentine (3 to 100 microM; P&lt;0.001). MK801 added early in the culture (for as little as 2-4 days) was as effective as addition for the entire culture period. Addition of MK801 for any time after day 7 of culture was ineffective in reducing osteoclast activity. Using rat and rabbit mature osteoclasts cultured on dentine or explants of mouse calvariae prelabeled with (45)Ca, we could not detect significant effects of MK801 on osteoclastic resorption. These data show clearly that glutamate receptor function is critical during osteoclastogenesis and suggest that glutamate is less important in regulating mature osteoclast activity.-Peet, N. M., Grabowski, P. S., Laketic-Ljubojevic, I., Skerry, T. M. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Peet</api:last-name><api:initials>NM</api:initials><api:first-names>NM</api:first-names><api:separate-first-names><api:first-name>N</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Biology, University of York, U.K. nmp2@york.ac.uk</api:line></api:address></api:addresses><api:email-address>nmp2@york.ac.uk</api:email-address></api:person><api:person><api:links><api:link type="elements/user" id="1105" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1105"/></api:links><api:last-name>Grabowski</api:last-name><api:initials>PS</api:initials><api:first-names>PS</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Laketic-Ljubojevic</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10593865</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1096/fasebj.13.15.2179</api:text><api:links><api:link type="doi" href="http://doi.org/10.1096/fasebj.13.15.2179"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1096/fasebj.13.15.2179"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0892-6638</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>15</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>FASEB J</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Actins</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Bone Resorption</api:keyword><api:keyword scheme="mesh">Cell Differentiation</api:keyword><api:keyword scheme="mesh">Dizocilpine Maleate</api:keyword><api:keyword scheme="mesh">Excitatory Amino Acid Antagonists</api:keyword><api:keyword scheme="mesh">Glutamic Acid</api:keyword><api:keyword scheme="mesh">In Vitro Techniques</api:keyword><api:keyword scheme="mesh">Ligands</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">N-Methylaspartate</api:keyword><api:keyword scheme="mesh">Osteoclasts</api:keyword><api:keyword scheme="mesh">Patch-Clamp Techniques</api:keyword><api:keyword scheme="mesh">Rabbits</api:keyword><api:keyword scheme="mesh">Rats</api:keyword><api:keyword scheme="mesh">Receptors, N-Methyl-D-Aspartate</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2179</api:begin-page><api:end-page>2185</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>6</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" id="881967" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10593865" last-modified-when="2024-04-09T19:40:45.063+01:00"><api:citation-count>64</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Recent identification in bone of transporters, receptors, and components of synaptic signaling suggests a role for glutamate in the skeleton. We investigated effects of glutamate and its antagonist MK801 on osteoclasts in vitro. Glutamate applied to patch clamped osteoclasts induced significant increases in whole-cell membrane currents (P&lt;0.01) in the presence of the coagonist glycine. Agonist-elicited currents were significantly decreased after application of MK801 (100 microM, P&lt;0.01), but MK801 had no effect on actin ring formation necessary for osteoclast polarization, attachment, and resorption. In cocultures of bone marrow cells and osteoblasts in which osteoclasts develop, MK801 inhibited osteoclast differentiation and reduced resorption of pits in dentine (3 to 100 microM; P&lt;0.001). MK801 added early in the culture (for as little as 2-4 days) was as effective as addition for the entire culture period. Addition of MK801 for any time after day 7 of culture was ineffective in reducing osteoclast activity. Using rat and rabbit mature osteoclasts cultured on dentine or explants of mouse calvariae prelabeled with (45)Ca, we could not detect significant effects of MK801 on osteoclastic resorption. These data show clearly that glutamate receptor function is critical during osteoclastogenesis and suggest that glutamate is less important in regulating mature osteoclast activity.-Peet, N. M., Grabowski, P. S., Laketic-Ljubojevic, I., Skerry, T. M. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Biology, University of York, U.K. nmp2@york.ac.uk</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Peet</api:last-name><api:initials>NM</api:initials><api:first-names>NM</api:first-names><api:separate-first-names><api:first-name>N</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1105" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1105"/></api:links><api:last-name>Grabowski</api:last-name><api:initials>PS</api:initials><api:first-names>PS</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>S</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0001-5924-1587</api:identifier></api:identifiers></api:person><api:person><api:last-name>Laketic-Ljubojevic</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0003-1319-5575</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1096/fasebj.13.15.2179</api:text><api:links><api:link type="doi" href="http://doi.org/10.1096/fasebj.13.15.2179"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1096/fasebj.13.15.2179"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1530-6860</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10593865</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0892-6638</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>15</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Osteoclasts</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Rabbits</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Rats</api:keyword><api:keyword scheme="mesh">Bone Resorption</api:keyword><api:keyword scheme="mesh">Dizocilpine Maleate</api:keyword><api:keyword scheme="mesh">Actins</api:keyword><api:keyword scheme="mesh">N-Methylaspartate</api:keyword><api:keyword scheme="mesh">Glutamic Acid</api:keyword><api:keyword scheme="mesh">Receptors, N-Methyl-D-Aspartate</api:keyword><api:keyword scheme="mesh">Excitatory Amino Acid Antagonists</api:keyword><api:keyword scheme="mesh">Ligands</api:keyword><api:keyword scheme="mesh">Patch-Clamp Techniques</api:keyword><api:keyword scheme="mesh">Cell Differentiation</api:keyword><api:keyword scheme="mesh">In Vitro Techniques</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2179</api:begin-page><api:end-page>2185</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>14</api:day><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" id="2472304" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1074561291" last-modified-when="2024-04-14T23:18:59.6+01:00"><api:citation-count>93</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>PEET</api:last-name><api:initials>NM</api:initials><api:first-names>NICKY M</api:first-names><api:separate-first-names><api:first-name>NICKY</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of York</api:line><api:line type="city">York</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.013122136034.00</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person><api:person><api:links><api:link type="elements/user" id="1105" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1105"/></api:links><api:last-name>GRABOWSKI</api:last-name><api:initials>PS</api:initials><api:first-names>PETER S</api:first-names><api:separate-first-names><api:first-name>PETER</api:first-name><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of York</api:line><api:line type="city">York</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0667041740.61</api:identifier></api:identifiers></api:person><api:person><api:last-name>LAKETIć‐LJUBOJEVIć</api:last-name><api:initials>I</api:initials><api:first-names>IRA</api:first-names><api:separate-first-names><api:first-name>IRA</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of York</api:line><api:line type="city">York</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01357150064.54</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>SKERRY</api:last-name><api:initials>TM</api:initials><api:first-names>TIM M</api:first-names><api:separate-first-names><api:first-name>TIM</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of York</api:line><api:line type="city">York</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.016145341616.12</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1096/fasebj.13.15.2179</api:text><api:links><api:link type="doi" href="http://doi.org/10.1096/fasebj.13.15.2179"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1096/fasebj.13.15.2179"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10593865</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0892-6638</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>15</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The FASEB Journal</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3208 Medical Physiology</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Osteoporosis</api:keyword><api:keyword scheme="hrcs-rac">1 Underpinning research</api:keyword><api:keyword scheme="hrcs-rac">1.1 Normal biological development and functioning</api:keyword><api:keyword scheme="hrcs-hc">Musculoskeletal</api:keyword><api:keyword scheme="mesh">Actins</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Bone Resorption</api:keyword><api:keyword scheme="mesh">Cell Differentiation</api:keyword><api:keyword scheme="mesh">Dizocilpine Maleate</api:keyword><api:keyword scheme="mesh">Excitatory Amino Acid Antagonists</api:keyword><api:keyword scheme="mesh">Glutamic Acid</api:keyword><api:keyword scheme="mesh">In Vitro Techniques</api:keyword><api:keyword scheme="mesh">Ligands</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">N-Methylaspartate</api:keyword><api:keyword scheme="mesh">Osteoclasts</api:keyword><api:keyword scheme="mesh">Patch-Clamp Techniques</api:keyword><api:keyword scheme="mesh">Rabbits</api:keyword><api:keyword scheme="mesh">Rats</api:keyword><api:keyword scheme="mesh">Receptors, N-Methyl-D-Aspartate</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Bronze OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2179</api:begin-page><api:end-page>2185</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>1.91</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" id="240986" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000084310800009" last-modified-when="2024-03-14T05:56:11.367+00:00"><api:citation-count>85</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Peet</api:last-name><api:initials>NM</api:initials><api:first-names>NM</api:first-names><api:separate-first-names><api:first-name>N</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1105" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1105"/></api:links><api:last-name>Grabowski</api:last-name><api:initials>PS</api:initials><api:first-names>PS</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Laketic-Ljubojevic</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000084310800009&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1096/fasebj.13.15.2179</api:text><api:links><api:link type="doi" href="http://doi.org/10.1096/fasebj.13.15.2179"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1096/fasebj.13.15.2179"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">266QN</api:identifier><api:identifier scheme="pubmed">10593865</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0892-6638</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>15</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>FASEB JOURNAL</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>osteoclast</api:keyword><api:keyword>differentiation</api:keyword><api:keyword>electrophysiology</api:keyword><api:keyword>glutamate receptor</api:keyword><api:keyword>MK801 maleate (Dizocilpine)</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2179</api:begin-page><api:end-page>2185</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>The glutamate receptor antagonist MK801 modulates bone resorption &lt;i&gt;in vitro&lt;/i&gt; by a mechanism predominantly involving osteoclast differentiation</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" id="23837" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000084310800009" last-modified-when="2014-07-25T11:04:48.803+01:00"><api:citation-count>59</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Peet</api:last-name><api:initials>NM</api:initials><api:first-names>NM</api:first-names><api:separate-first-names><api:first-name>N</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1105" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1105"/></api:links><api:last-name>Grabowski</api:last-name><api:initials>PS</api:initials><api:first-names>PS</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Laketic-Ljubojevic</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0892-6638</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>15</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>FASEB J</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>osteoclast</api:keyword><api:keyword>differentiation</api:keyword><api:keyword>electrophysiology</api:keyword><api:keyword>glutamate receptor</api:keyword><api:keyword>MK801 maleate (Dizocilpine)</api:keyword><api:keyword>VASOACTIVE-INTESTINAL-PEPTIDE</api:keyword><api:keyword>TYROSINE PHOSPHORYLATION</api:keyword><api:keyword>SEALING ZONE</api:keyword><api:keyword>NITRIC-OXIDE</api:keyword><api:keyword>CELLS</api:keyword><api:keyword>EXPRESSION</api:keyword><api:keyword>HORMONES</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2179</api:begin-page><api:end-page>2185</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword origin="record-data" source="manual">Actins Animals Bone Resorption Cell Differentiation Dizocilpine Maleate Excitatory Amino Acid Antagonists Glutamic Acid Ligands Mice N-Methylaspartate Osteoclasts Patch-Clamp Techniques Rabbits Rats Receptors, N-Methyl-D-Aspartate metabolism metabolism drug effects pharmacology pharmacology metabolism antagonists &amp; inhibitors drug effects metabolism</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Actins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Bone Resorption</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cell Differentiation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Dizocilpine Maleate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Excitatory Amino Acid Antagonists</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Glutamic Acid</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">In Vitro Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Ligands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">N-Methylaspartate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Osteoclasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Patch-Clamp Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Rabbits</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Rats</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Receptors, N-Methyl-D-Aspartate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Osteoclasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Rabbits</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Rats</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Bone Resorption</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Dizocilpine Maleate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Actins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">N-Methylaspartate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Glutamic Acid</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Receptors, N-Methyl-D-Aspartate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Excitatory Amino Acid Antagonists</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Ligands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Patch-Clamp Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cell Differentiation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">In Vitro Techniques</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3208 Medical Physiology</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Osteoporosis</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">1 Underpinning research</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">1.1 Normal biological development and functioning</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Musculoskeletal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Actins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Bone Resorption</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cell Differentiation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Dizocilpine Maleate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Excitatory Amino Acid Antagonists</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Glutamic Acid</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">In Vitro Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Ligands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">N-Methylaspartate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Osteoclasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Patch-Clamp Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Rabbits</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Rats</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Receptors, N-Methyl-D-Aspartate</api:keyword><api:keyword origin="record-data" source="wos-lite">osteoclast</api:keyword><api:keyword origin="record-data" source="wos-lite">differentiation</api:keyword><api:keyword origin="record-data" source="wos-lite">electrophysiology</api:keyword><api:keyword origin="record-data" source="wos-lite">glutamate receptor</api:keyword><api:keyword origin="record-data" source="wos-lite">MK801 maleate (Dizocilpine)</api:keyword><api:keyword origin="record-data" source="wos">osteoclast</api:keyword><api:keyword origin="record-data" source="wos">differentiation</api:keyword><api:keyword origin="record-data" source="wos">electrophysiology</api:keyword><api:keyword origin="record-data" source="wos">glutamate receptor</api:keyword><api:keyword origin="record-data" source="wos">MK801 maleate (Dizocilpine)</api:keyword><api:keyword origin="record-data" source="wos">VASOACTIVE-INTESTINAL-PEPTIDE</api:keyword><api:keyword origin="record-data" source="wos">TYROSINE PHOSPHORYLATION</api:keyword><api:keyword origin="record-data" source="wos">SEALING ZONE</api:keyword><api:keyword origin="record-data" source="wos">NITRIC-OXIDE</api:keyword><api:keyword origin="record-data" source="wos">CELLS</api:keyword><api:keyword origin="record-data" source="wos">EXPRESSION</api:keyword><api:keyword origin="record-data" source="wos">HORMONES</api:keyword><api:keyword scheme="for" origin="issn-inferred">0601 Biochemistry and Cell Biology</api:keyword><api:keyword scheme="for" origin="issn-inferred">0606 Physiology</api:keyword><api:keyword scheme="for" origin="issn-inferred">1116 Medical Physiology</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Biochemistry &amp; Molecular Biology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3101 Biochemistry and cell biology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3208 Medical physiology</api:keyword></api:keywords></api:all-labels><api:journal issn="0892-6638" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965520" title="The FASEB Journal"><api:records><api:record source-name="summary"><api:title>The FASEB Journal</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/662/relationships"/></api:object></api:result></api:response>